Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
MicroStrategy's Bitcoin Purchases Tend to Be Short-Term Negative for Prices, Research Shows

MicroStrategy's Bitcoin Purchases Tend to Be Short-Term Negative for Prices, Research Shows

CoindeskCoindesk2023/06/28 19:11
By:Omkar Godbole

Past data shows bitcoin tends to drop 2% on the day MSTR announces new purchases.

Early Wednesday, business intelligence firm MicroStrategy (MSTR) the purchase of over 12,000 bitcoin (BTC) for $347 million. The fresh accumulation has boosted the company's coin stash to 152,333 BTC.

So far, MicroStrategy's announcement failed to spur bullish action in the bitcoin market, allowing bitcoin to retreat to the lower end of the recent trading range of $30,000 to $31,000.

The dull market response is consistent with the cryptocurrency's record of losing some ground following MicroStrategy's announcements of new coin purchases of over 1,000 BTC, according to data analyzed by K33.

"MicroStrategy BTC purchase announcements tend to be followed by short-term negative price action in BTC, as the market absorbs the fact that certain buy-side liquidity has left the market," Vetle Lunde, research analyst at K33, told CoinDesk.

CoinDesk - Unknown

Since 2020, bitcoin has registered an average daily return of negative 2% on days of MSTR announcements. The average weekly return following MSTR's announcement is slightly positive.

"The short-term impact tends to reverse in the days that follow, and there are no clear evidence of a prolonged adverse market impact on MicroStrategy announcements, with the average weekly return sitting in slight positive territory," Lunde said.

MicroStrategy began adding bitcoin to its balance sheet three years ago as a hedge against the Federal Reserve’s the-then ultra easy monetary policy. Recently, MicroStrategy’s CEO Micheal Saylor that the crypto market is likely to become BTC-centric due to the recent U.S. regulatory crackdown on the digital assets industry.

Edited by Oliver Knight.


44
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

BCH has surged by 35.79% since the beginning of the year, reflecting the overall positive sentiment in the market.

- Bitcoin Cash (BCH) fell 0.1% in 24 hours but rose 35.79% year-to-date, outperforming peers. - Sustained 7-day (7.55%) and 1-month (9.1%) gains highlight growing institutional and retail confidence. - Market adoption in DeFi and low-cost transactions, plus macroeconomic optimism, drive BCH's long-term appeal. - Analysts predict continued growth as BCH's ecosystem matures and on-chain activity rises.

Bitget-RWA2025/12/04 01:04

Solana's Sharp Drop: Causes Behind the Fall and Future Prospects for Investors

- Solana's 30% price drop in late 2025 contrasts with strong on-chain metrics like 400ms finality and $35.9B DEX volume, but declining user engagement and rising NVT ratios signaled overvaluation. - Macroeconomic factors including high interest rates and institutional caution reduced speculative demand, with ETF inflows favoring staking products over direct price support. - Whale accumulation and RWA growth (up 350% YoY) suggest strategic buying during dips, though active address recovery and NVT normaliza

Bitget-RWA2025/12/04 00:54
Solana's Sharp Drop: Causes Behind the Fall and Future Prospects for Investors

The Increasing Expenses of Dementia Treatment and Their Influence on Healthcare Investment Prospects

- Global dementia cases surge to 55M in 2025, projected to triple to 139M by 2050 due to aging populations and Alzheimer's rise. - U.S. dementia costs hit $781B in 2025, with Medicare/Medicaid covering $164B and families paying $52B out-of-pocket. - Home healthcare and AI caregiver tech markets grow rapidly (10-17% CAGR), reaching $381B and $5.3B by 2033-2032 respectively. - Dementia biotech faces risks but attracts $3.1B in Q3 2025 venture funding (+70.9% QoQ), despite $161M losses at Alector/Denali. - St

Bitget-RWA2025/12/04 00:38
The Increasing Expenses of Dementia Treatment and Their Influence on Healthcare Investment Prospects
© 2025 Bitget